Discussant review - FINE-HEART

13 May 2024 (09:14 - 09:18)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Petar Seferovic

Faculty of Medicine, University of Belgrade, Belgrade (Serbia)

9 More presentations in this session

Presentation thumbnail

Effect of IV iron in patients with heart failure with preserved ejection fraction

Professor S. von Haehling (Goettingen, DE)

Presentation thumbnail

Discussant review - FAIR-HFpEF

Professor P. Kalra (Portsmouth, GB)

Presentation thumbnail

Semaglutide 2.4 mg and NTproBNP in obesity-related HFpEF: insights from the STEP-HFpEF programme

Professor M. Petrie (Glasgow, GB)

Presentation thumbnail

Discussant review - STEP HFpEF Program

Professor A. Bayes Genis (Badalona, ES)

Presentation thumbnail

Design and baseline characteristics of REALIZE K: a placebo-controlled randomized-withdrawal trial of sodium zirconium cyclosilicate for hyperkalaemia management in patients with HF and reduced EF

Doctor M. Kosiborod (Kansas City, US)

Access the full session

Session thumbnail

Late breaking clinical trials: further analyses and baseline characteristics

The Event

Event poster

Heart Failure 2024

13 May 2024 09:14 CET

You may be interested in

Congress Presentation

Design and baseline characteristics of FINE-HEART: an integrated pooled analysis of finerenone in >19,000 participants across 3 phase III trials of HF & CKD

Congress Presentation

Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART Pooled Analysis of Cardiovascular, Kidney, and Mortality Outcomes

Congress Presentation

Improving outcomes for the heart and kidney: the role of mineralocorticoid receptor antagonists (MRAs)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources